stockportfolio.pro
Stocks / PFE vs SYK
PFE vs SYK
Pfizer Inc. and Stryker Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Pfizer Inc. (PFE) | Stryker Corporation (SYK) | |
|---|---|---|
| Market cap | $148.2B | $118.1B |
| Revenue (latest FY) | $62.58B | $25.12B |
| Net income (latest FY) | $7.77B | $3.25B |
| Revenue growth (5y CAGR) | 8.5% | 11.8% |
| Net margin | 12.4% | 12.9% |
| Return on equity | 9.0% | 14.5% |
| P/E ratio | 19.8 | 35.6 |
| Dividend yield | 6.6% | 1.1% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open PFE — free Open SYK — freeFrequently asked questions
Which is bigger, PFE or SYK?
Pfizer Inc. is larger by market capitalization — $148.2B versus $118.1B.
Which grows faster, PFE or SYK?
Over the last five fiscal years, Stryker Corporation grew revenue faster — 11.8%/yr versus 8.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.